⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2057453 | 0.80 | — | — | |
| Ammonia Solution, Strong SCHEMBL27522184 | 0.72 | — | — | |
| SCHEMBL4965995 | 0.72 | — | — | |
| Ammonia Solution, Strong SCHEMBL22836740 | 0.70 | — | — | |
| SCHEMBL4869266 | 0.70 | — | — | |
| SCHEMBL8426535 | 0.69 | — | — | |
| SCHEMBL30065764 | 0.67 | — | — | |
| SCHEMBL7529329 | 0.65 | — | — | |
| Guanidine SCHEMBL2057451 | 0.64 | CA1 (0.55) | — | |
| Guanidine SCHEMBL735066 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100092972-A1 | ASSAY FOR GENE EXPRESSION | HUMAN GENETIC SIGNATURES PTY LTD. (AU) | 2010-04-15 | — | — | US | claimed |
| US-7501240-B2 | Method for bisulfite treatment | ROCHE MOLECULAR SYSTEMS, INC. (US) | 2009-03-10 | — | — | US | claimed |
| US-20070190530-A1 | Method for bisulfite treatment | ROCHE MOLECULAR SYSTEMS, INC. | 2007-08-16 | — | — | US | claimed |
| EP-1692315-A1 | IMPROVED METHOD FOR BISULFITE TREATMENT | Roche Diagnostics GmbH (DE) | 2006-08-23 | — | — | EP | claimed |
| WO-2005054502-A1 | IMPROVED METHOD FOR BISULFITE TREATMENT | ROCHE DIAGNOSTICS GMBH (DE) | 2005-06-16 | — | — | WO | claimed |
| EP-2016188-B1 | METHODS FOR DETECTION OF METHYLATED DNA | JIA XIYU (US) | 2015-10-21 | — | — | EP | disclosed |
| EP-2330214-B1 | Method for DNA decontamination | HOFFMANN LA ROCHE (CH) | 2015-03-04 | — | — | EP | disclosed |
| EP-1789586-B1 | DNA DECONTAMINATION METHOD | ROCHE DIAGNOSTICS GMBH (DE) | 2014-12-31 | — | — | EP | disclosed |
| US-8137937-B2 | Conversion of cytosine base in nucleic acid to uracil base via sulfite deamination; determining methylation positions in nucleotide sequences | ROCHE MOLECULAR SYSTEMS, INC. (US) | 2012-03-20 | — | — | US | disclosed |
| US-7989169-B2 | Selective amplification of methylated nucleic acids | ROCHE MOLECULAR SYSTEMS, INC. (US) | 2011-08-02 | — | — | US | disclosed |
| EP-2330214-A1 | Method for DNA decontamination | F. Hoffmann-La Roche AG (CH) | 2011-06-08 | — | — | EP | disclosed |
| EP-1963352-B1 | NEW METHOD FOR BISULFITE TREATMENT | ROCHE DIAGNOSTICS GMBH (DE) | 2010-09-08 | — | — | EP | disclosed |
| US-20070190530-A1 | Method for bisulfite treatment | ROCHE MOLECULAR SYSTEMS, INC. | 2007-08-16 | — | — | US | disclosed |
| WO-2007068437-A1 | NEW METHOD FOR BISULFITE TREATMENT | ROCHE DIAGNOSTICS GMBH (DE) | 2007-06-21 | — | — | WO | disclosed |
| EP-1789586-A2 | DNA DECONTAMINATION METHOD | Roche Diagnostics GmbH (DE) | 2007-05-30 | — | — | EP | disclosed |
| EP-1692315-A1 | IMPROVED METHOD FOR BISULFITE TREATMENT | Roche Diagnostics GmbH (DE) | 2006-08-23 | — | — | EP | disclosed |
| EP-1692315-A1 | IMPROVED METHOD FOR BISULFITE TREATMENT | Roche Diagnostics GmbH (DE) | 2006-08-23 | — | — | EP | disclosed |
| WO-2006024541-A2 | DNA DECONTAMINATION METHOD | ROCHE DIAGNOSTICS GMBH (DE) | 2006-03-09 | — | — | WO | disclosed |
| WO-2005054502-A1 | IMPROVED METHOD FOR BISULFITE TREATMENT | ROCHE DIAGNOSTICS GMBH (DE) | 2005-06-16 | — | — | WO | disclosed |
| WO-2005054502-A1 | IMPROVED METHOD FOR BISULFITE TREATMENT | ROCHE DIAGNOSTICS GMBH (DE) | 2005-06-16 | — | — | WO | disclosed |